XCath secures FDA breakthrough designation for remote thrombectomy robot

With the FDA designate in hand, XCath will further the development of its system that is intended to broaden access to stroke treatment globally. With the FDA designate in hand, XCath will further the development of its system that is intended to broaden access to stroke treatment globally. XCath completed the world’s first remote telerobotic mechanical thrombectomy in a living patient in March 2026. Credit: Poetra.RH/Shutterstock.com XCath Robotics’ Iris, a remote robotic-assisted system for performing mechanical thrombectomy in acute ischemic stroke patients, has secured breakthrough device designation from the US Food and Drug Administration (FDA) – paving the way for…

Source: Medical Device Network